Clinical trial Recruiting at 1 site Observational Ages 18 and up

Automated robotic monitoring of blood flow in traumatic brain injury patients

Official title: Automated Robotic TCD in Traumatic Brain Injury (ART-TBI)

Run by Virginia Commonwealth University · NCT05848297 · Data updated 2026-11-12

This study is testing if a new robotic system that monitors blood flow can safely help doctors gather important information about patients with severe brain injuries.

More Brain Injuries, Traumatic trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorVirginia Commonwealth University
Academic / other
Locations3 sites (Davis, California and 2 other locations)
StatusRecruiting
StartedMay 20, 2025
Main results expectedMay 2027
Study endsMay 2027
Registry record updatedJune 3, 2026
Trial IDNCT05848297 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with blunt TBI and a Glasgow Coma Score of 8 or lower, who have sustained their injury within the last 72 hours.

Probably not a fit

Patients with catastrophic brain injuries, severe skull injuries, or those requiring immediate surgical intervention may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the safety, feasibility, and efficacy of prolonged automated robotic transcranial Doppler (TCD) monitoring in critically ill patients suffering from severe traumatic brain injury (TBI). Participants will undergo daily monitoring sessions lasting up to 4 hours for a minimum of 3 days, utilizing a robotic TCD system that continuously records cerebral blood flow velocity in the middle cerebral artery. The study will also gather feedback from healthcare providers regarding the implementation of this monitoring protocol. The goal is to determine whether this technology can provide meaningful clinical data while ensuring patient safety.

Why it matters

Potential benefit: If successful, this study could enhance monitoring techniques for patients with severe TBI, potentially leading to improved patient outcomes.

How similar studies have gone: While this approach is innovative, similar studies have not been widely reported, indicating that this may be a novel application of robotic TCD monitoring.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults ≥18
* Blunt TBI with Glasgow Coma Score (GCS) ≤8
* Injury within 72 hours
* Adequate TCD windows
* Ability to obtain informed consent from a Legally Authorized Representative (LAR)

Exclusion Criteria:

* Catastrophic brain injury with grim prognosis (e.g.: GCS 3 with bilateral mid-position pupil)
* C- spine fracture with evidence of spinal cord injury
* Severe skull or scalp injury precluding device placement
* Planned decompressive hemicraniectomy
* Continuous fever for \>6 hours at the time of enrollment (despite treatment)
* Lack of TCD window

Where it's running

  • Virginia Commonwealth University
    Richmond, Virginia, United States
    Recruiting
  • University of California, Davis
    Davis, California, United States
    Not yet recruiting
  • Wake Forest University
    Winston-Salem, North Carolina, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.